Phentermine/fenfluramine decreases cocaine self-administration in rhesus monkeys

NeuroReport

Volumn 8, Issue 6, 1997, Pages 1347-1351

  Glowa, John R ^a,b,d   Rice, Kenner C ^b   Matecka, Dorota ^b   Rothman, Richard B ^c  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Cocaine; Drug abuse; Fenfluramine; Food maintained behavior; Phentermine; Rhesus monkeys; Self administration behavior

Indexed keywords

COCAINE; FENFLURAMINE; PHENTERMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; DRUG SELF ADMINISTRATION; FOOD INTAKE; INSTRUMENTAL CONDITIONING; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SUBSTANCE ABUSE;

EID: 0031006690     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199704140-00006     Document Type: Article

References (25)

1. Glowa JR, Wojnicki FHE, Matecka D et al. Exp Clin Psychopharmacol 3, 219-231 (1995).
2. Glowa JR, Wojnicki FHE, Matecka D et al. Exp Clin Psychopharmacol 3, 232-239 (1995).
3. Glowa JR, Fantegrossi WE, Lewis D et al. J Med Chem 39, 4689-4691 (1996).
4. Glowa JR and Wojnicki FHE. Psychopharmacology 128, 351-358 (1996).
5. Mello NK and Negus SS. Neuropsychopharmacology 14, 375-424 (1996).
6. Hitzig P. Maryland Med J 42, 153-156 (1993).
7. Rothman RB, Gendron T and Hitzig P. J Sub Abuse Treat 11, 273-275 (1994).
8. Rothman RB. J Subst Abuse Treat 12, 449-153 (1995).
9. Weintraub M, Hasday JD, Mushlin AI et al. Arch Intern Med 144, 1143-1148 (1984).
10. Silverstone T. Drugs 43, 820-836 (1992).
11. Samanin R and Garattini S. Pharmacol Toxicol 73, 63-68 (1993).
12. Ayestas M, Baumann MH and Rothman RB. NIDA Res Monogr 153, 404 (1994).
13. Baumann MH, Char GU de Costa BR et al. J Pharmacol Exp Ther 271, 1216-1222 (1994).
14. Wojnicki FHE, Bacher JD and Glowa JR. Lab Anim Sci 44, 491-494 (1994).
15. Downs DA and Woods JH. J Pharmacol Exp Ther 191 179-188 (1974).
16. Brauer LH, Johanson C, Schuster CR et al. Neuropsychopharmacology 14, 233-241 (1996).
17. Di Chiara G and Imperato A. Proc Natl Acad Sci USA 85, 5274-5278 (1988).
18. Rothman RB, Ayestas M and Baumann MH. NeuroReport 8, 7-9 (1996).
19. Koetzner L, Riley AL and Glowa JR. Pharmacol Biochem Behav 54, 517-523 (1996).
20. Griffiths RR, Brady JV and Snell JD. .Biol Psychiatry 13, 283-290 (1978).
21. Wojnicki FHE and Glowa JR. Psychopharmacology 123, 34-41, 1996.
22. Yanagita T. Bull Narcotics 25, 57-64 (1973).
23. Hodos W. Science 134, 943-944 (1961).
24. Carroll ME and Boe IN. Pharmacol Biochem Behav 17, 563-567 (1982).
25. Rothman RB and Glowa JR. Mol Neurobiol 10, 1-19 (1995).